LncRNA HCP5 is Highly Expressed in Gestational Diabetes Mellitus to Suppress Insulin Secretion

Abstract excerpt

Purpose: LncRNA HCP5 has been reported to participate in high glucose-induced pathological processes, whereas its role in gestational diabetes mellitus (GDM) is unclear. This study aimed to explore the role of HCP5 in GDM. Methods: This study enrolled a total of 220 pregnant women (gestational age = 1 month). A follow-up study was performed until delivery. The occurrence of GDM was checked every month during...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Apelin-related biomedical research
• Share to Gestational Diabetes Research and Management
• Share to Pregnancy and preeclampsia studies